A personalised vaccine against melanoma can more than double the survival
rate for patients with the advanced form of this skin cancer. Doctors at
Jefferson Medical College in Philadelphia create customised vaccines from
patients’ own cancer cells by inactivating them and altering their surface
proteins with dinitrophenol. Five-year survival rates in 214 patients with
advanced disease increased from around 20 per cent to 50 per cent and a
randomised phase III trial of 400 patients across the US is planned.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
How autoimmune conditions can unexpectedly drive mental illness
3
A key solution to climate change isn't happening – and that's good
4
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
5
Hospital-acquired pneumonia reduced by daily toothbrushing
6
How to spot the Lyrid meteor shower tonight
7
Largest ever map of universe captures 47 million galaxies and quasars
8
The biggest threat to Chernobyl is no longer radiation
9
Food shock is inevitable due to the Iran war – and it could get bad
10
Ancient crocodile relative could have ripped dinosaurs apart
